BIGNOPE
Ko-fi

Recalls affecting West Virginia

Data last updated: September 7, 2026 at 12:15 AM UTC

16,312 recalls found

Just announced

Straight from FDA press releases — not yet formally classified or risk-graded
UnclassifiedUndeclaredAnnounced September 4, 2026

Business Pill, Branch Manager for Mendietary supplements marketed for male sexual enhancement

Products contain undeclared yohimbine

Full report
Dietary SupplementsFood & Beverages

Recalling firm: SUPPLX.com

Grant-Valkaria, Florida - SUPPLX.com is voluntarily recalling Business Pill and Branch Manager for Men, products marketed as dietary supplements for male sexual enhancement, because FDA laboratory analysis confirmed that both products contain yohimbine that is not declared on the product labels.

Company contact: (321) 341-9501 · SupplxRecall@gmail.com

View FDA’s announcement (opens in a new tab)
UnclassifiedBacteria/virusAnnounced September 4, 2026

Foods AliveMoringa Leaf Powder

Potential to be contaminated with Salmonella

Full report
Food & BeveragesFoodborne Illness

Recalling firm: Foods Alive Inc.

Foods Alive Inc of Angola, IN, is recalling its 8-ounce packages of organic moringa leaf powder because they have the potential to be contaminated with Salmonella , an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

View FDA’s announcement (opens in a new tab)
UnclassifiedAnnounced September 3, 2026

B. Braun0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container

Presence of particulate matter identified as iron oxide

Full report
Drugs

Recalling firm: B. Braun Medical Inc.

“On September 3, 2026 firm updated their press release to include additional contaminants.” FOR IMMEDIATE RELEASE – September 3, 2026– Bethlehem, PA, B. Braun Medical Inc (B. Braun) is voluntarily recalling three (3) lots of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container, to the hospital/healthcare facility/user level due to presence of particulate matter identified as iron…

Company contact: recalls@bbraunusa.com

View FDA’s announcement (opens in a new tab)
UnclassifiedBacteria/virusAnnounced September 3, 2026

Great ValueOrganic Triple Berry Blend

Possible E. Coli Contamination

Full report
Food & BeveragesFoodborne Illness

Recalling firm: Frutas y Hortalizas del Sur S.A.

September 02, 2026. Frutas y Hortalizas del Sur S.A., San Carlos, Chile expands its July 3, 2026, recall of frozen organic IQF blueberries to include one lot of Great Value frozen Organic Triple Berry Blend 10 OZ because of potential contamination with Escherichia coli O145:H28 (E. coli O145) .

Company contact: Info.foodsafety@comfrut.com

View FDA’s announcement (opens in a new tab)
UnclassifiedAnnounced September 3, 2026

American Regent, Inc.Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vial

Presence of particulate matter and lack of sterility assurance

Full report
Food & Beverages

Recalling firm: American Regent, Inc.

FOR IMMEDIATE RELEASE – September 3, 2026 – New Albany, OH, American Regent, Inc. is conducting a nationwide voluntary recall of three lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vials to the consumer level. Customer complaints were received for leaking and cracked vials, resulting in lack of assurance of sterility.

View FDA’s announcement (opens in a new tab)
UnclassifiedUndeclaredAnnounced August 31, 2026

LipofitLipofit Extreme 2.0 Fat Burner Dietary Supplement

Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)

Full report
Dietary SupplementsDrugs

Recalling firm: Ana Salazar Modela Tu Cuerpo Inc.

FOR IMMEDIATE RELEASE - August 27, 2026 - Davie, Florida – Ana Salazar Modela Tu Cuerpo Inc. is recalling Lipofit Extreme Fat Burner 2.0, Lot 25M12F, expiration date 09/2027, to the consumer level.

Company contact: (954) 305-1004 · yandrydy@gmail.com

View FDA’s announcement (opens in a new tab)
UnclassifiedAnnounced August 31, 2026

KofinasGarlic Mediterranean Infused Extra Virgin Olive Oil 500 ml, 250 ml, and 100 ml

Contains garlic essential oil not approved for culinary use

Full report
Food & BeveragesIngredients

Recalling firm: LMSI LLC

Cincinnati, OH (Aug. 29, 2026) - LMSI LLC/ Kofinas Olive Oil is issuing a voluntary recall of its Garlic Mediterranean infused extra virgin olive oil for using a garlic essential oil not approved for culinary use. The flavored oil was bottled in glass bottles in 500 ml, 250 ml, and 100 ml sizes.

View FDA’s announcement (opens in a new tab)
UnclassifiedAllergenUndeclaredAnnounced August 31, 2026

Little TemptationsChocolatey Eyeballs, 7 oz., 10 oz., 10.5 oz., 11 oz., and 16 oz.

Undeclared milk

Full report
Food & BeveragesAllergens

Recalling firm: Crystal Temptations

Crystal Temptations of North Arlington, NJ is recalling Halloween Chocolatey Eyeballs because they contain undeclared MILK allergens. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products.

View FDA’s announcement (opens in a new tab)
UnclassifiedBacteria/virusAnnounced August 29, 2026

Everything SproutsRobust Radish Mix, 5oz Cups

Potential to be contaminated with Shiga toxin-producing Escherichia coli (STEC) or Salmonella.

Full report
Food & BeveragesFoodborne Illness

Recalling firm: Everything Sprouts, LLC

Everything Sprouts, LLC, based in Minneapolis, MN is expanding its voluntary recall of sprouts to include certain lots of Robust Radish Sprout Mix because it has the potential to be contaminated with Shiga toxin producing Escherichia coli (STEC) or Salmonella bacteria.

Company contact: everythingsproutsmn@gmail.com

View FDA’s announcement (opens in a new tab)
UnclassifiedBacteria/virusAnnounced August 29, 2026

MartinaMangoes

Potential contamination with Salmonella

Full report
Food & BeveragesFoodborne Illness

Recalling firm: Panorama Produce

MAMARONECK, NY, AUG. 28, 2026 - Panorama Produce is recalling 302 boxes of size 9 (nine) mangoes because they may be contaminated with Salmonella , an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

Company contact: information@panoramaproduce.com

View FDA’s announcement (opens in a new tab)
Wording
Class IIModerate risk
DrugRecalled May 29, 2013

Furosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-730-2013
Lot/product code:
A5029 Exp 11/30/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Ceftiofur GM vial 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-712-2013
Lot/product code:
K5520 Exp 11/23/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Pento-Gluc 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-767-2013
Lot/product code:
B0521 Exp 8/21/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-747-2013
Lot/product code:
B0005 Exp 8/5/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Polidocanol (0.75%, 1%, 3%, and 10%) Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-773-2013
Lot/product code:
0.75% Lot L5611 Exp 11/30/13 // 1% Lot b3001 Exp 6/19/13, B5014 Exp 8/14/13, and A5431 Exp 6/4/13 // 3% Lot A5808 Exp 12/31/13 // 10% Lot C5328 Exp 9/3/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Naproxen 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-762-2013
Lot/product code:
K5013 Exp 11/30/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-794-2013
Lot/product code:
A5615 Exp 6/6/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Acepromazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-693-2013
Lot/product code:
B0112 exp 08/31/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Neomycin / Polymyxin / Dexamethasone Ophthalmic Drops, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-763-2013
Lot/product code:
A5531 Exp 6/5/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Doxapram 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-725-2013
Lot/product code:
B0105 Exp 8/19/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Deslorelin 15 mg vial, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-716-2013
Lot/product code:
A3021 Exp 6/2/13 and L5011 exp 12/11/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Gentamicin 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-733-2013
Lot/product code:
B5014 Exp 8/13/13 and C3913 Exp 9/9/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-728-2013
Lot/product code:
C51212 Exp 8/12/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Methylcobalamin 1 mg/ml / Folic Acid 2.5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-756-2013
Lot/product code:
L3326 Exp 6/30/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Yohimbine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-796-2013
Lot/product code:
A5008 Exp 12/31/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Gaba 50 mg/Mag Sulfate 50 mg/Taurine/Theanine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-731-2013
Lot/product code:
C3729 Exp 9/7/13
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled May 29, 2013

Clenbuterol 0.03mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Not guaranteed to be germ-free: FDA inspection findings resulted in concerns regarding quality control processes

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-714-2013
Lot/product code:
A0107 Exp 01/31/14
Recalling firm:
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled April 29, 2014

Vitamin C (ascorbic acid) Injection, USP, 500 mg per 2 mL, 50 x 2 mL ampoules per box, Manufactured by: TP Drug Laboratories (1969) Co., Ltd., 98 Soi Sukhumvlt 62, Yak 1, Bangchak, Prakanong, Bangkok 10260, Thailand, Reg. No. 1 A 1557/30; UPC 8 853533 000533

Marketed Without An Approved NDA/ANDA: Parenteral product is sold over the counter whose labeling indicates it is to be used for the treatment of disease.

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-1320-2014
Lot/product code:
Lot #: 556273, Exp 9/25/16; 556219, Exp 8/2/16, or any other lot distributed by Flawless Beauty.
Recalling firm:
Flawless Beauty LLC
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled April 29, 2014

Relumins Advanced Glutathione (lyophilized glutathione/vitamin C) injectable solution, 1500 mg/500 mg, packaged in 8-count vials, 8-count 5 mL vitamin C (ascorbic acid) solution diluent ampoules, and 30-count Advanced Glutathione Boosters capsules per box, Relumins Labs, 183 Locust Avenue, West Long Branch, NJ 07764, UPC 700175760302

Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be used parenterally for drug claims.

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-1319-2014
Lot/product code:
Lot #: 130616, Exp 06/16
Recalling firm:
Flawless Beauty LLC
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled April 29, 2014

Laroscorbine Platinium (vitamin C/collagen) injectable I.V. solution, 1 gm/0.35 gm, 5 mL ampoules, packaged in 10-count ampoules per box, Laboratories Roche Nicholas S.A., F-74240 Gaillard, - Tel.: 04 50 87 70 70, Fabricant : Produits Roche, 52, Bld du Parc, 92521 Neulilly -sur-Seine Cedex, barcode *3421357*

Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-1316-2014
Lot/product code:
Lot #: F040, Exp 08/16
Recalling firm:
Flawless Beauty LLC
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled April 29, 2014

Sterile Water for Injection, 5 mL ampoules, packaged in 50-count ampoules per box, Manufactured and Distributed by: Euro Med Laboratories, UPC 4800573016219

Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be used for parenteral injection.

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-1321-2014
Lot/product code:
Lot #: 16U394, Exp 04/16; 16U421, Exp 08/16; 16U423, Exp 09/16
Recalling firm:
Flawless Beauty LLC
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled April 29, 2014

Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box, Manufactured by: Sujie Pharmaceutical Ltd., Tokyo, Japan, UPC 4973430081576

Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-1317-2014
Lot/product code:
Lot #: UB302, Exp 05/12/15
Recalling firm:
Flawless Beauty LLC
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled April 29, 2014

Saluta (reduced glutathione) Powder for Injection, 600 mg/vial, packaged in 10 vials per box, Exclusively Distributed by: QAF Pharmaceuticals Inc. Philippines, Unit Unit 202 ECG Building, Multinational Avenue, Multinational Village, Parahaque City, Metro Manila Philippines; Manufactured by: Shandong Luye Pharmaceutical Co. Ltd, Yantai Shandong, PRC la Luye Pharma Subsidiary, UPC 6920425209014

Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote.

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-1318-2014
Lot/product code:
Lot #: 201302275, Exp 01/20/15; 201308384, Exp 10/19/2015
Recalling firm:
Flawless Beauty LLC
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled June 30, 2015

KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49

Crystallization; identified as calcium salt of Ketorolac

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-1242-2015
Lot/product code:
31075DK, 31076DK, EXP01JUL2015; 32345DK, 32368DK, EXP 01AUG2015; 33152DK, EXP 01SEP2015; 34538DK, EXP 01OCT2015; 37227DK, EXP 01JAN2016, 41525DK, 42255DK, EXP 01MAY2016; 46042DK, 46045DK, 46048DK, 46304DK, 46305DK, 46432DK, 46433DK, EXP 01OCT2016 AND NOVAPLUS LOT 31074DK, EXP 01JUL2015
Recalling firm:
Hospira Inc.
View official FDA record (opens in a new tab)
Class IIModerate risk
DrugRecalled June 30, 2015

KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49

Crystallization; identified as calcium salt of Ketorolac

ALL 50 STATES
Full report

A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.

Recall #:
D-1241-2015
Lot/product code:
31077DK, 31078DK, 31338DK, 31339DK, 31340DK, EXP 01JUL2015; 32068DK, 32069DK, EXP 01AUG2915; 33270DK, EXP 01SEP2015; 34084DK, 34085DK, 34161DK, 34162DK, 34298DK, 34299DK, 34300DK, EXP 01OCT2015; 35011DK, 35081DK, 35082DK, 35116DK, EXP 01NOV2015; 38139DK, 38140DK, 36144DK, EXP 01FEB2016; 39256DK, 39257DK, EXP 01MAR2016; 42210DK, 42227DK, EXP01JUN2016; 43017DK, 43116DK, 43117DK, 43292DK, 43293DK, EXP 01JUL2016; 45034DK, 45035DK, 45118DK, 45120DK, EXP 01SEP2016; 46310DK, 46311DK, EXP 01OCT2016 AND NOVAPLUS LOTS 32106DK, 32220DK, 32221DK, EXP 01AUG2015; 33235DK, 33236DK, EXP 01SEP2015; 34163DK, 34164DK, EXP 01OCT2015; 39263DK, 39264DK, EXP 01MAR2016
Recalling firm:
Hospira Inc.
View official FDA record (opens in a new tab)